Michał Mączewski

1.6k total citations
63 papers, 1.2k citations indexed

About

Michał Mączewski is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Michał Mączewski has authored 63 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Michał Mączewski's work include Cardiac electrophysiology and arrhythmias (17 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac Ischemia and Reperfusion (11 papers). Michał Mączewski is often cited by papers focused on Cardiac electrophysiology and arrhythmias (17 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac Ischemia and Reperfusion (11 papers). Michał Mączewski collaborates with scholars based in Poland, United Kingdom and France. Michał Mączewski's co-authors include A Beresewicz, Urszula Mackiewicz, E. Czarnowska, Halina Dobrzynski, Monika Duda, Mark R. Boyett, Joseph Yanni, James O. Tellez, Cezary Szczylik and Rafał Stec and has published in prestigious journals such as Scientific Reports, American Journal Of Pathology and British Journal of Pharmacology.

In The Last Decade

Michał Mączewski

61 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michał Mączewski 567 386 204 154 111 63 1.2k
Hiroyuki Yaoita 574 1.0× 621 1.6× 354 1.7× 115 0.7× 100 0.9× 52 1.4k
Masakatsu Wakeno 409 0.7× 436 1.1× 219 1.1× 102 0.7× 38 0.3× 13 1.0k
Yun-He Liu 1.1k 2.0× 594 1.5× 234 1.1× 265 1.7× 86 0.8× 23 1.9k
Yu‐Ting Xuan 460 0.8× 581 1.5× 272 1.3× 160 1.0× 65 0.6× 15 1.2k
Xiaomang You 481 0.8× 491 1.3× 178 0.9× 369 2.4× 188 1.7× 29 1.5k
Jiang Xu 988 1.7× 718 1.9× 184 0.9× 233 1.5× 111 1.0× 60 1.9k
Ting C. Zhao 186 0.3× 806 2.1× 199 1.0× 313 2.0× 104 0.9× 46 1.5k
Kevin A. Krown 447 0.8× 573 1.5× 196 1.0× 106 0.7× 42 0.4× 8 1.1k
Mirella Coppo 731 1.3× 318 0.8× 70 0.3× 137 0.9× 99 0.9× 47 1.2k
Hiroe Toba 490 0.9× 486 1.3× 97 0.5× 159 1.0× 97 0.9× 52 1.3k

Countries citing papers authored by Michał Mączewski

Since Specialization
Citations

This map shows the geographic impact of Michał Mączewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michał Mączewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michał Mączewski more than expected).

Fields of papers citing papers by Michał Mączewski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michał Mączewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michał Mączewski. The network helps show where Michał Mączewski may publish in the future.

Co-authorship network of co-authors of Michał Mączewski

This figure shows the co-authorship network connecting the top 25 collaborators of Michał Mączewski. A scholar is included among the top collaborators of Michał Mączewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michał Mączewski. Michał Mączewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urbanowicz, Krzysztof, et al.. (2025). Dapagliflozin, An SGLT2 Inhibitor, Improves Endothelial Cell Energy Metabolism Through Enhanced Mitochondrial Respiration. Cellular Physiology and Biochemistry. 59(2). 235–251. 2 indexed citations
2.
Mączewski, Michał, et al.. (2025). Special focus on the mitochondria in endothelial cells: A novel therapeutic target for gliflozins?. Biomedicine & Pharmacotherapy. 188. 118210–118210.
3.
Mączewski, Michał, et al.. (2025). Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 Inhibitors. Pharmaceuticals. 18(3). 313–313. 8 indexed citations
4.
Torbicki, Adam, et al.. (2024). Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat. British Journal of Pharmacology. 181(20). 4050–4066. 1 indexed citations
5.
Kalisz, Małgorzata, et al.. (2024). Epicardial fat in heart failure—Friend, foe, or bystander. Obesity Reviews. 25(12). e13820–e13820. 6 indexed citations
6.
Mączewski, Michał, et al.. (2024). Epicardial fat density obtained with computed tomography imaging - more important than volume?. Cardiovascular Diabetology. 23(1). 389–389. 7 indexed citations
7.
Duda, Monika, et al.. (2024). Sex- and age-dependent susceptibility to ventricular arrhythmias in the rat heart ex vivo. Scientific Reports. 14(1). 3460–3460. 2 indexed citations
8.
Mackiewicz, Urszula, Cezary Szczylik, Marcin Kurzyna, et al.. (2023). Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension. JACC Heart Failure. 12(2). 235–247. 6 indexed citations
9.
Pilch, Zofia, Anna Sosnowska, Urszula Mackiewicz, et al.. (2023). Arginase Inhibition Mitigates Bortezomib-Exacerbated Cardiotoxicity in Multiple Myeloma. Cancers. 15(7). 2191–2191. 4 indexed citations
10.
11.
Chajduk, Ewelina, et al.. (2021). Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure. Journal of Molecular and Cellular Cardiology. 159. 16–27. 9 indexed citations
12.
Mackiewicz, Urszula, et al.. (2020). Treatment of hypoxia‐dependent cardiovascular diseases by myo‐inositol trispyrophosphate (ITPP)‐enhancement of oxygen delivery by red blood cells. Journal of Cellular and Molecular Medicine. 24(3). 2272–2283. 6 indexed citations
13.
Nowis, Dominika, Michał Mączewski, Urszula Mackiewicz, et al.. (2010). Cardiotoxicity of the Anticancer Therapeutic Agent Bortezomib. American Journal Of Pathology. 176(6). 2658–2668. 101 indexed citations
14.
Mackiewicz, Urszula, et al.. (2010). Brief postinfarction calcineurin blockade affects left ventricular remodeling and Ca2+ handling in the rat. Journal of Molecular and Cellular Cardiology. 48(6). 1307–1315. 11 indexed citations
15.
Musa, Hanny, James O. Tellez, Natalie Chandler, et al.. (2009). P2 purinergic receptor mRNA in rat and human sinoatrial node and other heart regions. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(6). 541–549. 40 indexed citations
16.
Stec, Rafał, Bartłomiej Grala, Michał Mączewski, Lubomir Bodnar, & Cezary Szczylik. (2009). Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease. Journal of Experimental & Clinical Cancer Research. 28(1). 134–134. 44 indexed citations
17.
Mączewski, Michał, et al.. (2007). Late ventricular remodeling in non-reperfused acute myocardial infarction in humans is predicted by angiotensin II type 1 receptor density on blood platelets. International Journal of Cardiology. 127(1). 57–63. 6 indexed citations
18.
Mączewski, Michał, et al.. (2006). Hypercholesterolemia Exacerbates Ventricular Remodeling in the Rat Model of Myocardial Infarction. Journal of Cardiac Failure. 12(5). 399–405. 26 indexed citations
19.
Mączewski, Michał, et al.. (2005). Angiotensin II AT1 Receptor Density on Blood Platelets Predicts Early Left Ventricular Remodelling in Non-Reperfused Acute Myocardial Infarction in Humans. European Journal of Heart Failure. 8(2). 173–178. 5 indexed citations
20.
Mączewski, Michał & A Beresewicz. (1998). The Role of Adenosine and ATP-sensitive Potassium Channels in the Protection Afforded by Ischemic Preconditioning Against the Post-ischemic Endothelial Dysfunction in Guinea-pig Hearts. Journal of Molecular and Cellular Cardiology. 30(9). 1735–1747. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Yaoita Breakdown of academic impact, for papers by Masakatsu Wakeno Breakdown of academic impact, for papers by Yun-He Liu Breakdown of academic impact, for papers by Yu‐Ting Xuan Breakdown of academic impact, for papers by Xiaomang You Breakdown of academic impact, for papers by Jiang Xu Breakdown of academic impact, for papers by Ting C. Zhao Breakdown of academic impact, for papers by Kevin A. Krown Breakdown of academic impact, for papers by Mirella Coppo Breakdown of academic impact, for papers by Hiroe Toba
Rankless by CCL
2026